Ever read a post about a company and just wonder d if the poster was struggling with depression or attention deficit disorder?
I am impressed with the speed the company has responded to the adjusted protocol and got the IND submitted. This, in collaboration with the FDA and their advice plus Healey, Berry and our Scientific Advisory Committee (leaders in ALS research) is fully expected to receive a letter within a month which then allows the Healey platform to submit an adjustment to their trial to include regimen H (NUZ001). Once the FDA approve that change, good to go and go it will.
adreamer
Ann: Neurizon Files IND Application to Support HEALEY ALS Trial, page-53
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $81.23M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.5¢ | $23.56K | 141.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 30232 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 13227 | 2 |
View Market Depth
| Last trade - 15.37pm 24/06/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |